ATH Medical Joins the Sterimed Group to Boost its Growth

STERIMED and the shareholders of ATH Medical have finalized an agreement whereby Sterimed now holds a 70% stake in ATH Medical.

Geoffrey Broninx, Chairman and Founder of ATH Medical, retains a 30% stake in this company, which specializes in traceability systems for surgical instruments.

Founded in 2013, ATH Medical has developed solutions to meet the increasing needs for traceability within healthcare centers, with products such as WhiteReader® and Ancitrak®, which enhance productivity in surgical suites and sterilization centers and improve safety in the assembly of surgical trays.

ATH Medical won the Innoster prize in 2014 and first prize in the science category at the World Federation for Hospital Sterilization Services in 2016 (for its work in partnership with the Lille University Hospital (CHRU)) and is already selling its products in 11 countries across three continents with a subsidiary in Hong Kong.

Sterimed, global provider of sterilization packaging and infection control with manufacturing and sales operations in more than 70 countries, will let ATH Medical set its sights higher by boosting the company’s growth and providing support for its personnel.

Broninx says, “We are very pleased to receive this endorsement from the STERIMED Group. There are obvious synergies between our two companies, which will allow us to progress faster and further. To accelerate its development, ATH needed support and resources for R&D and to improve its regulatory and sales functions, and we are confident that we have found the right partner."

Thibaut Hyvernat, Sterimed CEO, notes, “We have been very impressed by the ATH Medical teams, by their energy and motivation, and by the products they have developed. This relatively new start-up has already enjoyed a series of successes and has all the strengths of a large company. We believe that the cooperation between our teams will spur on the two companies and lift our innovative endeavours to the next level for the benefit of both customers and patients. We shall do everything we can to help the ATH teams reach and exceed its goals.”

More in Home